Cargando…
Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
Meibomian gland dysfunction (MGD) is believed to be the leading cause of dry eye (DE) disease worldwide. The connection between aging and MGD has long been recognized. However, few studies have addressed the relationship between MGD and hormone replacement therapy (HRT) in perimenopausal women, and...
Autores principales: | Jin, Xiuming, Lin, Zhenyun, Liu, Yufang, Lin, Lin, Zhu, Binbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979784/ https://www.ncbi.nlm.nih.gov/pubmed/27495030 http://dx.doi.org/10.1097/MD.0000000000004268 |
Ejemplares similares
-
Association analysis between vitamin D level and depression in women perimenopause: A protocol of systematic review and meta-analysis
por: Yuan, Jie, et al.
Publicado: (2020) -
Acupuncture combined with SSRIs in the treatment of perimenopausal depressive disorder: A protocol for systematic review and meta-analysis
por: Gao, Zhan, et al.
Publicado: (2022) -
Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy
por: Hassan, Fatima, et al.
Publicado: (2023) -
Non-pharmacological therapies for treating chronic pelvic pain in women: A review
por: Wang, Xinlu, et al.
Publicado: (2022) -
Correlation between bone mineral density of different sites and lumbar disc degeneration in postmenopausal women
por: Zhou, Lin, et al.
Publicado: (2022)